Early Detection     Genetics     Treatment


Glaucoma is the second most common cause of blindness in the world and the leading cause of blindness irreversible via current medical technology. There are two forms, with primary open-angle glaucoma predominating in Europe and North America and primary angle-closure glaucoma most common in Asia. Increased intraocular pressure is a major risk factor and although pressure can be reduced via surgery, subsequent scarring reduces beneficial effects. We have pioneered treatments to inhibit scarring and further innovations are in the pipeline. It is very important to detect disease early and we are studying vision tests and imaging techniques to improve screening and monitoring of disease progression. We are also developing screening programmes for angle-closure glaucoma. Finally, with colleagues in Moorfields, we are investigating the genetic basis of the disease.

IO researchers working in this area:

Dr Maryse Bailly
Professor Shomi Bhattacharya
Professor Francesca Cordeiro
Dr Steven Dakin
Professor Fred Fitzke
Dr Paul Foster
Mr D Garway Heath
Professor Peng Khaw
Dr Astrid Limb
Mr Ian Murdoch
Mr Ananth Viswanathan

You need to upgrade your Flash Player